Evidence map›Paper›PMID 34902662›Full record

ArticleEpilepsy & behavior : E&B2022

Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2.

Chiara Milano, Francesco Turco, Chiara Pizzanelli, Alessia Pascazio, Enrico Tagliaferri, Lorenzo Nesti, Mauro Pistello, Anna Lisa Capria, Francesco Menichetti, Francesco Forfori and 2 more

Open access · greenAbstract read
In one paragraph

Article in Epilepsy & behavior : E&B, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Chiara MilanoNeurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Francesco TurcoNeurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Chiara PizzanelliNeurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Electronic address: c.pizzanelli@ao-pisa.toscana.it.
Alessia PascazioNeurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Enrico TagliaferriInfectious Diseases Unit, Pisa University Hospital, Pisa, Italy.
Lorenzo NestiInfectious Diseases Unit, Pisa University Hospital, Pisa, Italy.
Mauro PistelloVirology Unit, Pisa University Hospital, Pisa, Italy; Retrovirus Center and Virology Section, Department of Translational Research, University of Pisa, Pisa, Italy.
Anna Lisa CapriaVirology Unit, Pisa University Hospital, Pisa, Italy.
Francesco MenichettiInfectious Diseases Unit, Pisa University Hospital, Pisa, Italy.
Francesco ForforiDepartment of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
Enrica BonanniNeurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Gabriele SicilianoNeurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
University of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies reported acute symptomatic seizures as a possible neurological complication of COVID-19 pneumonia. Apart from metabolic imbalances, hypoxia, and fever, other ictogenic mechanisms are likely related to an immune-mediated damage. The same mechanisms are shared by other respiratory viruses. Since neurotropic properties of SARS-CoV-2 have been questioned, we investigated whether SARS-CoV-2 has a similar ictogenic potential to other respiratory non-neurotropic viruses. We conducted a retrospective study identifying 1141 patients with SARS-CoV-2 pneumonia and 146 patients with H1N1/H3N2 pneumonia. We found a similar prevalence of seizures in the two viral pneumonia (1.05% with SARS-CoV-2 vs 2.05% with influenza; p = 0.26). We detailed clinical, electroencephalographic, and neuroradiological features of each patient, together with the hypothesized pathogenesis of seizures. Previous epilepsy or pre-existing predisposing conditions (i.e., Alzheimer's disease, stroke, cerebral neoplasia) were found in one-third of patients that experienced seizures, while two-thirds of patients had seizures without known risk factors other than pneumonia in both groups. The prevalence of pre-existing predisposing conditions and disease severity indexes was similar in SARS-CoV-2 and H1N1/H3N2 pneumonia, thus excluding they could act as potential confounders. Considering all the patients with viral pneumonia together, previous epilepsy (p < 0.001) and the need for ventilatory support (p < 0.001), but not the presence of pre-existing predisposing conditions (p = 0.290), were associated with seizure risk. Our study showed that SARS-CoV-2 and influenza viruses share a similar ictogenic potential. In both these infections, seizures are rare but serious events, and can manifest without pre-existing predisposing conditions, in particular when pneumonia is severe, thus suggesting an interplay between disease severity and host response as a major mechanism of ictogenesis, rather than a virus-specific mechanism.

Indexed as

COVID-19Influenza A Virus, H1N1 SubtypePneumonia, ViralHumansInfluenza A Virus, H3N2 SubtypeRetrospective StudiesSARS-CoV-2SeizuresIctogenic potentialInfluenzaPneumoniaSARS-CoV-2Seizures

Identifiers

PMID34902662
PMCPMC8661132
OpenAlexW4200620346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.